These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 3657388)

  • 21. Conditioned stereotypy: behavioral specification of the UCS and pharmacological investigation of the neural change.
    Hiroi N; White NM
    Pharmacol Biochem Behav; 1989 Jan; 32(1):249-58. PubMed ID: 2543991
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conditioning of pre- and post-synaptic behavioural responses to the dopamine receptor agonist apomorphine in rats.
    Möller HG; Nowak K; Kuschinsky K
    Psychopharmacology (Berl); 1987; 91(1):50-5. PubMed ID: 3029794
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Striatal tissue transplants attenuate apomorphine-induced rotational behavior in rats with unilateral kainic acid lesions.
    Norman AB; Calderon SF; Giordano M; Sanberg PR
    Neuropharmacology; 1988 Mar; 27(3):333-6. PubMed ID: 3374772
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rotational behavior as a classically conditioned response to pentobarbital administration.
    Silverman PB; Grabowski J; Lane KE
    Eur J Pharmacol; 1992 Mar; 212(2-3):165-9. PubMed ID: 1601063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conditioning of behavioural effects produced by an intermediate dose of apomorphine: hypokinesia, ptosis and stereotypies.
    Nowak K; Kuschinsky K
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Sep; 336(3):262-6. PubMed ID: 3683596
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lesions of substantia nigra by kainic acid: effects on apomorphine-induced stereotyped behaviour.
    Morelli M; Porceddu ML; Di Chiara G
    Brain Res; 1980 Jun; 191(1):67-78. PubMed ID: 7189684
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of acute L-Dopa pretreatment on apomorphine-induced rotational behavior in a rat model of Parkinson's disease.
    Mandel RJ
    Exp Neurol; 2000 Jan; 161(1):212-9. PubMed ID: 10683287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conditioning the placebo response in the rotational model of Parkinson's disease.
    Burunat E; Diaz Palarea MD; Castro R; Rodriguez M
    Funct Neurol; 1987; 2(3):263-9. PubMed ID: 3692271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apomorphine and amphetamine stereotypy after 6-hydroxydopamine lesions of the substantia nigra.
    Price MT; Fibiger HC
    Eur J Pharmacol; 1974 Dec; 29(2):249-52. PubMed ID: 4613562
    [No Abstract]   [Full Text] [Related]  

  • 30. Drug conditioning induced by intrastriatal apomorphine administration.
    Pinheiro Carrera M; Brunhara FC; Schwarting RK; Tomaz C
    Brain Res; 1998 Apr; 790(1-2):60-6. PubMed ID: 9593824
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Classically conditioned ethanol stimulus control of a motor behavior.
    Silverman PB
    Alcohol; 1990; 7(6):489-92. PubMed ID: 2261085
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence for a role of endogenous opioids in the nigrostriatal system: influence of naloxone and morphine on nigrostriatal dopaminergic supersensitivity.
    Hirschhorn ID; Hittner D; Gardner EL; Cubells J; Makman MH
    Brain Res; 1983 Jun; 270(1):109-17. PubMed ID: 6409355
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conditioning of apomorphine effects: simultaneous analysis of the alterations in cortical electroencephalogram and behaviour.
    Kropf W; Kuschinsky K; Krieglstein J
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Jun; 343(6):559-67. PubMed ID: 1944603
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-specific supersensitivity of striatal dopamine receptors after 6-hydroxydopamine lesion of the nigrostriatal pathway.
    Costall B; Naylor RJ; Pycock C
    Eur J Pharmacol; 1976 Feb; 35(2):276-83. PubMed ID: 942921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microdialysis study of striatal dopamine in MPTP-hemilesioned rats challenged with apomorphine and amphetamine.
    Dombrowski PA; Carvalho MC; Miyoshi E; Correia D; Bortolanza M; Dos Santos LM; Wietzikoski EC; Eckart MT; Schwarting RK; Brandão ML; Da Cunha C
    Behav Brain Res; 2010 Dec; 215(1):63-70. PubMed ID: 20600337
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pirouetting pigs: A large non-primate animal model based on unilateral 6-hydroxydopamine lesioning of the nigrostriatal pathway.
    Christensen AB; Sørensen JCH; Ettrup KS; Orlowski D; Bjarkam CR
    Brain Res Bull; 2018 May; 139():167-173. PubMed ID: 29462643
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rats with unilateral median forebrain bundle, but not striatal or nigral, lesions by the neurotoxins MPP+ or rotenone display differential sensitivity to amphetamine and apomorphine.
    Sindhu KM; Banerjee R; Senthilkumar KS; Saravanan KS; Raju BC; Rao JM; Mohanakumar KP
    Pharmacol Biochem Behav; 2006 Jun; 84(2):321-9. PubMed ID: 16820197
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lesioning of the striatum reverses motor asymmetry in the 6-hydroxydopamine rodent model of parkinsonism.
    Friehs GM; Parker RG; He LS; Haines SJ; Turner DA; Ebner TJ
    J Neural Transplant Plast; 1991; 2(2):141-56. PubMed ID: 1684115
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Operant control of turning in circles: a new model of dopaminergic drug action.
    Glick SD
    Brain Res; 1982 Aug; 245(2):394-7. PubMed ID: 6889903
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Neurophysiologic and pharmacologic evidence of autoregulationin the nigrostriatal system].
    Arushanian EB; Tolpyshev BA
    Biull Eksp Biol Med; 1981 Feb; 91(2):133-6. PubMed ID: 7194700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.